POSACONAZOLE IN PROPHYLAXIS OF FUNGAL INFECTIONS IN NEUTROPENIC PATIENTS A SINGLE CENTRE EXPERIENCE

被引：0
|
作者：
Zappone, E. [1 ]
Nardelli, S. [1 ]
Coppetelll, U. [1 ]
La Barbera, E. Ortu [1 ]
Centra, A. [1 ]
Ciabatta, C. [1 ]
Ciccone, F. [1 ]
Potente, G. [1 ]
De Blasio, A. [1 ]
机构：
[1] Osped SM Goretti, Latina, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0865
引用
收藏
页码：360 / 361
页数：2
相关论文
共 50 条
  • [21] Single Arm, Single Centre Prospective Study to Assess the Effect of Therapeutic Drug Monitoring (TDM) Based Dosage Adjustment of Posaconazole on the Incidence of Invasive Fungal Infections (IFIs) in AML Patients on Induction Chemotherapy on Posaconazole Prophylaxis
    Sengar, Manju
    Boppana, Mounika
    Jain, Hasmukh
    Gota, Vikram
    Bagal, Bhausaheb
    Gokarn, Anant
    Gujrar, Murari
    Ambotkar, Madhavi
    BLOOD, 2019, 134
  • [22] COST UTILITY OF POSACONAZOLE VERSUS FLUCONAZOLE/ITRACONAZOLE THERAPY IN THE PROPHYLAXIS AGAINST INVASIVE FUNGAL INFECTIONS AMONG HIGH-RISK NEUTROPENIC PATIENTS IN MEXICO
    Rely, K.
    Pierre, K. A.
    Salinas, E. G.
    VALUE IN HEALTH, 2009, 12 (03) : A50 - A50
  • [23] A single centre experience of treatment outcomes during three antimycotic prophylaxis periods in patients with AML: Itraconazole versus posaconazole versus no prophylaxis
    Hahn-Ast, C.
    Glasmacher, A.
    Mueckter, S.
    Landwehr, C.
    Schmitz, A.
    Mayer, K.
    Marklein, G.
    Brossart, P.
    von Lilienfeld-Toal, M.
    ONKOLOGIE, 2011, 34 : 256 - 256
  • [24] COST UTILITY OF POSACONAZOLE VERSUS FLUCONAZOLE/ITRACONAZOLE THERAPY IN THE PROPHYLAXIS AGAINST INVASIVE FUNGAL INFECTIONS AMONG HIGH-RISK NEUTROPENIC PATIENTS IN MEXICO
    Rely, K.
    Pierre, K. A.
    Salinas, E. G.
    VALUE IN HEALTH, 2009, 12 (07) : A490 - A491
  • [25] TRIMETHOPRIM SULFAMETHOXAZOLE PROPHYLAXIS IN NEUTROPENIC PATIENTS - REDUCTION OF INFECTIONS AND EFFECT ON BACTERIAL AND FUNGAL FLORA
    KAUFFMAN, CA
    LIEPMAN, MK
    BERGMAN, AG
    MIODUSZEWSKI, J
    AMERICAN JOURNAL OF MEDICINE, 1983, 74 (04): : 599 - 607
  • [26] Posaconazole prophylaxis in neutropenic patients with hematological malignancies: limits in clinical practice
    Bourdelin, Magali
    Grenouillet, Frederic
    Daguindau, Etienne
    Muret, Patrice
    Desbrosses, Yohan
    Dubut, Jonathan
    Deconinck, Eric
    Limat, Samuel
    Larosa, Fabrice
    MEDICAL MYCOLOGY, 2014, 52 (07) : 728 - 735
  • [27] Posaconazole's impact on prophylaxis and treatment of invasive fungal infections: an update
    Smith, Winter J.
    Drew, Richard H.
    Perfect, John R.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2009, 7 (02) : 165 - 181
  • [28] Incidence of breakthrough fungal infections on isavuconazole prophylaxis compared to posaconazole and voriconazole
    Scott, Sara A.
    Perry, Cory
    Mahmoudjafari, Zahra
    Martin, Grace A.
    Boyd, Samuel
    Thompson, Jeffrey
    Thomas, Beth
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (02)
  • [29] COST-ANALYSIS OF POSACONAZOLE FOR PROPHYLAXIS AGAINST FUNGAL INFECTIONS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES IN QATAR
    Al Marridi, W.
    Al Hijji, I
    ElAzzazy, S.
    Nounou, A.
    Hamad, A.
    Al-Badriyeh, D.
    VALUE IN HEALTH, 2018, 21 : S64 - S64
  • [30] The role of nursing care in the prophylaxis of fungal infections in children after bone marrow transplants single-centre experience
    Krukowska, J
    BONE MARROW TRANSPLANTATION, 2005, 35 : S307 - S307
12345